openPR Logo
Press release

Appointment of LITMUS Molecular Design President

07-03-2007 04:05 PM CET | Science & Education

Press release from: LITMUS LLC

/ PR Agency: Abchurch
LITMUS LLC, a leading global technology innovations company, today announces that Dr. Bill W. Massey has been appointed as President of its wholly owned subsidiary, LITMUS Molecular Design (“LMD”).

LMD is dedicated to the discovery and development of new molecular entities for the pharmaceutical, chemical and materials science industries. LMD’s technology dramatically improves the efficiency and predictive accuracy of the discovery and development process thereby substantially reducing the associated time and costs. Consequently LMD is able to generate significant value for users of its technology in their commercialization of new molecular entities.

LMD creates new molecular entities designed to have specified desired properties and characterizes the activity of existing molecules through the use of LITMUS Spectral Modeling, the application of its patented, cutting edge methodology called Spectral Data Activity Relationship (SDAR). The method uses computer modeling techniques to predict the properties that a molecular structure will exhibit based solely on spectral analysis (LITMUS Spectral Modeling). This removes the need to physically create the molecule and exhaustively test for which individual properties it possesses. LMD can also screen existing molecules for desirable, or undesirable, activity. As all of these capabilities are assessed in silico (on the computer), the time and cost are greatly reduced. Developed by scientists at the U.S. Food and Drug Administration (FDA)’s National Center for Toxicological Research, LITMUS Spectral Modeling can predict a wide range of a given molecular structure’s scientifically important properties, including chemical reactivity, carcinogenicity, biological activity, receptor-binding affinity, toxicity, metabolism, absorption, and chemical and physical properties. LMD owns the worldwide license on LITMUS Spectral Modeling.

LMD offers both products and services to its customers. LITMUS Molecular Entity Design (“L-MED”) is focused on creation of new chemical entities with specific biological activity, while LITMUS Molecular Analysis Services (“L-MAS”) is focused on the development of custom predictive models of biological activity.

Dr. Massey has had a successful 15 year career in the pharmaceutical industry, spanning a variety of areas including pre-clinical research, clinical research, regulatory affairs, marketing, and business operations/planning. He has held senior management positions at Astra Merck Inc., Quintiles Central Nervous System (CNS) Therapeutics Inc., Scirex Corporation, and AstraZeneca plc. He has actively managed the preparation and submission of a number of original investigational new drug and product marketing applications, and has leadership experience in international drug development programs in the cardiovascular and CNS therapeutic areas. Dr. Massey received his PhD from the Department of Pharmacology and Interdisciplinary Toxicology of the University of Arkansas for Medical Sciences. He currently holds two adjunct faculty appointments in pharmacology, at the University of Arkansas for Medical Sciences, and psychiatry, at the University of Mississippi Medical Center, where he lectures on the pharmacology of anti-psychotics and antidepressants, and on development of drugs for neurological and psychiatric diseases.

Mark Diggs, Chief Executive Officer of LITMUS, commented: “This is a significant milestone in the development of LITMUS Molecular Design. With Dr. Massey’s appointment, LMD becomes fully operational and LITMUS Spectral Modeling will now be commercially available to the pharmaceutical, chemical, and materials sciences industries.”

Founded in 2002, LITMUS, LLC is headquartered in Little Rock, Arkansas USA, and has offices across America and in London, England. For more information, visit www.litmusgti.com.

LITMUS LLC
9821 Katy Freeway
Suite 500
Houston
Texas 77024
USA

Mark Diggs, Chief Executive Officer
Tel: 1 713 464 7770
mdiggs@litmusgti.com

For media enquiries:
Abchurch
Gareth Mead
Tel: 44 (0) 20 7398 7700
gareth.mead@abchurch-group.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Appointment of LITMUS Molecular Design President here

News-ID: 23411 • Views: 1614

More Releases from LITMUS LLC

Second Exclusive Cooperative Research Agreement with US Naval Air Warfare Center …
LITMUS, LLC, a leading global technology innovations company, today announces that its majority owned subsidiary, LITMUS Defense, LLC, has entered into a formal agreement with the U.S. Naval Air Warfare Center Weapons Division (NAWCWD), for the research and development of carbon nanostructures in advanced composite structures. The NAWCWD is the premier research and development center within the Naval Air Systems Command, conducting basic and applied research of advanced technologies related to
LITMUS Defense in Exclusive US Naval Air Warfare Center Cooperative Research Agr …
LITMUS, LLC, a leading global technology innovations company, today announces that its majority owned subsidiary, LITMUS Defense, LLC, has entered into a formal agreement with the U.S. Naval Air Warfare Center, Weapons Division (NAWCWD), for the research and development of carbon nanostructures in advanced rocket motors and warheads. The NAWCWD is the premier research and development center within the Naval Air Systems Command, conducting basic and applied research of advanced technologies
LITMUS and FDA Collaboration Leads to Global Food Safety Breakthrough
LITMUS, LLC, a leading global technology innovations company, announces today a breakthrough which will dramatically improve current testing methods to detect food borne pathogens such as Salmonella, Listeria, Campylobacter, and E.coli. This advancement in bacterial pathogen-testing technology provides growers, producers and processors quicker and more accurate results, thereby reducing the risk of contaminated foods reaching consumers. The new procedures are the result of a two-year collaboration between LITMUS
Appointment of LITMUS Defense CEO to Nanotechnology Board
LITMUS, LLC, a leading global technology innovations company, today announces that Bill Nevius, President and CEO of its wholly owned subsidiary, LITMUS Defense LLC, has been selected to join the Board of Directors of the Colorado Nanotechnology Alliance for 2007. The Alliance is a non-for-profit corporation established in 2006 to advance economic development in the State of Colorado, with a focus on the use of nanotechnology. The Alliance partners with

All 5 Releases


More Releases for LMD

Worldwide Emegring Trends of Laser Microdissection Market - Potential Growth and …
The report on Global Laser Microdissection Market 2020 includes a study of annual and financial reports of top players, Market Share and Market Size. This research report offers in-depth study of Key Players, Product and Regional Analysis over the forecast period (2020-2024). Global Laser Microdissection Market overview: BIR Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Laser Capture MicrodissectionMarket Research Report: Size, Share, Growth, Trends …
Laser Capture Microdissection Market report provides a basic overview of the Laser Capture Microdissection industry including definitions, classifications, applications and industry chain structure. Also the market provides development policies, plans, manufacturing processes and cost structures. Scope of the Report: This report focuses on the Air Curtain in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application. Get
Latest Research Report on Laser Capture Microdissection Market Predicts Favorabl …
Laser Capture Microdissection (LCM) technology is a contagion free process for obtaining sub-populations of tissue cells under direct microscopic apparition. In addition, laser-capture Microdissection technology isolates specific cells by dissecting unwanted cells. Laser Capture Microdissection technology harvests the cells of attention straight to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The Laser Capture Microdissection technology by type can
EMEA (Europe, Middle East and Africa) Industrial 3D Printings Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "EMEA (Europe, Middle East and Africa) Industrial 3D Printings Market Report 2017" Description In this report, the EMEA Industrial 3D Printings market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With
Global Industrial 3D Printings Market Research Report 2017 Industry Solutions - …
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Industrial 3D Printings in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Industrial 3D Printings market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Stratasys 3D Systems Corporation Materialise EOS Exone Company Voxeljet Arcam Group SLM Solutions Group Envisiontec Sciaky Oxford Performance Materials Renishaw PLC Koninklijke DSM Concept Laser Hoganas Scuplteo Book a
Consumer 3D printing market is growing at a very fast pace with 45% CAGR for nex …
The Inception of 3D printing happened in 90’s but was chained to industrial application. From past 5 years the industry marked its entrance into consumer products. The Consumer 3D printing market is growing at a very fast pace with 45% CAGR for next five years. The pullulating market is supported by strong demand from the consumers. By the early 2010s, the terms 3D printing and additive manufacturing developed senses in